Cancer Stories
Didn't see your exact story?
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
Cancer Stories
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
37 stories match debulking. 35 of them mention surgery.
Cancer Stories
Ovarian CancerStage I Ovarian Cancer: Jane's Survivor Story
Patient Info: Jane McGrath, female, 40s | Stage I
Ovarian CancerStage IV Ovarian Cancer: Manisha's Survivor Story
Patient Info: Manisha Koirala, Female | Stage IV
Ovarian CancerStage II Ovarian Squamous Cell Carcinoma: Caitlin's Survivor Story
Patient Info: Caitlin Koehler, female, Under 40 | Stage II
Biomarkers: PD-L1: high expression
Ovarian CancerStage IV Ovarian Cancer First Found Through an Umbilical Metastasis
Patient Info: Anonymized, female, 60s | Stage IV
Biomarkers: WT1-positive; CK7-positive; CA-125 321 U/mL at diagnosis
Metastatic Site: umbilicus
Ovarian CancerDurable response after multiple treatments for ovarian clear cell cancer
Patient Info: Anonymized, Female, 40s | Stage III
Biomarkers: HRD-positive; BRCA-negative; ARID1A mutation; PD-L1 CPS 30
Ovarian CancerOvarian Cancer: Hope's Patient Story
Patient Info: Hope Aguilar, female
Ovarian CancerOvarian Cancer Remission With Olaparib After Chemotherapy Intolerance
Patient Info: Anonymized, female, 50s | Stage III
Biomarkers: germline BRCA1 mutation
Breast CancerTriple-negative metastatic breast cancer with pituitary metastasis: symptom relief after debulking
Patient Info: Anonymized, Female, 60s | Stage IV
Biomarkers: Pituitary metastasis was triple-negative breast cancer with no HER2 amplification.
Metastatic Site: liver; bone/skull; right breast; left orbit/optic…
Breast CancerBreast cancer survivor with synchronous intercostal nerve schwannomas mimicking metastasis
Patient Info: Anonymized, Female, Under 40
Biomarkers: Breast cancer biomarkers not reported; schwannomas were S100-positive
Ovarian CancerStage III BRCA1 Ovarian Cancer: Carla's Survivor Story
Patient Info: Carla Peoples, female | Stage III
Biomarkers: BRCA1 mutation
Lung CancerRecurrent Lung Adenocarcinoma Complicated by a Tracheopericardial Fistula
Patient Info: Anonymized, male, 70+ | Stage II
Biomarkers: No gene mutations identified on postoperative testing
Ovarian CancerOvarian Cancer: Lissa's Survivor Story
Patient Info: Lissa Fancher
Ovarian CancerStage IV Ovarian Cancer: Susan's Patient Story
Patient Info: Susan Dunwoody, female | Stage IV
Lung CancerStage I Lung Cancer: Lauren's Patient Story
Patient Info: Lauren Koy, Female, Under 40 | Stage I
Biomarkers: CD56-positive neuroendocrine tumor; no gene mutations reported
Ovarian CancerOvarian cancer chemotherapy continued after paclitaxel-related liver injury
Patient Info: Anonymized, Female, 50s | Stage II
Biomarkers: somatic BRCA1/2 negative
Ovarian CancerStage III Ovarian Cancer: Karoline's Patient Story
Patient Info: Karoline Strauss, female | Stage III
Lung CancerECMO-Supported Airway Tumor Removal in Stage IIB Lung Cancer
Patient Info: Anonymized, Male, 50s | Stage II
Ovarian CancerStage 4 Ovarian Cancer Discovered During Trigeminal Neuralgia Evaluation
Patient Info: Anonymized, Female, 50s | Stage IV
Ovarian CancerEmergency Surgery for a Malignant Brenner Tumor Causing Bowel Obstruction
Patient Info: Anonymized, Female, 60s
Biomarkers: CA-125 184.2 U/mL
Ovarian cancer that later spread to an axillary lymph node
Patient Info: Anonymized, Female, 60s | Stage IV
Metastatic Site: axillary lymph nodes
Advanced Ovarian Cancer Presenting With Dermatomyositis
Patient Info: Anonymized, Female, 50s
Biomarkers: CA-125 3169 at diagnosis; later CA-125 rise with progression
Ovarian Cancer With Pleural Spread and Recurrent Dermatomyositis
Patient Info: Anonymized, Female, 40s | Stage Metastatic/Advanced
Metastatic Site: pleura
Recurrent Ovarian Cancer With Dermatomyositis and Peritoneal Progression
Patient Info: Anonymized, Female, 50s
Lung CancerLung cancer presenting with brain and leptomeningeal spread
Patient Info: Anonymized, Male, 70+ | Stage IV
Biomarkers: PD-L1 100%; EGFR negative; ALK rearrangement negative
Metastatic Site: brain, leptomeninges